Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$278M |
| 2 |
Exxon Mobil
XOM
|
$270M |
| 3 |
Verizon
VZ
|
$141M |
| 4 |
Yum China
YUMC
|
$135M |
| 5 |
Chevron
CVX
|
$122M |
Top Sells
Sector Composition
| 1 | Financials | 17.74% |
| 2 | Technology | 15.29% |
| 3 | Industrials | 12.37% |
| 4 | Healthcare | 11.81% |
| 5 | Consumer Discretionary | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Black Diamond Therapeutics
BDTX
$167M
| $101K | ﹤0.01% |
+60,046
| New | +$101K |
|
3327
Comstock Holding Companies
CHCI
$187M
| $101K | ﹤0.01% |
25,592
| – | – |
|
3328
Iterum Therapeutics
ITRM
$30.3M
| $101K | ﹤0.01% |
+62,301
| New | +$101K |
|
3329
X4 Pharmaceuticals
XFOR
$78.6M
| $101K | ﹤0.01% |
1,977
-70
| -3% | -$3.58K |
|
|
APRN
3330
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
| $101K | ﹤0.01% |
1,452
| – | – |
|
|
SRGA
3331
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $101K | ﹤0.01% |
29,240
-439
| -1% | -$1.52K |
|
3332
KORU Medical Systems
KRMD
$188M
| $100K | ﹤0.01% |
44,661
+16,454
| +58% | +$36.8K |
|
3333
MediciNova
MNOV
$63.3M
| $100K | ﹤0.01% |
46,099
-2,575
| -5% | -$5.59K |
|
|
AKUS
3334
DELISTED
Akouos, Inc. Common Stock
AKUS
| $100K | ﹤0.01% |
14,766
-1,061
| -7% | -$7.19K |
|
3335
Neonode
NEON
$85.8M
| $99K | ﹤0.01% |
28,402
+15,553
| +121% | +$54.2K |
|
3336
GrowGeneration
GRWG
$90.3M
| $98K | ﹤0.01% |
+28,107
| New | +$98K |
|
|
HYFT
3337
MindWalk Holdings Corp. Common Stock
HYFT
$89.5M
| $98K | ﹤0.01% |
24,573
+9,209
| +60% | +$36.7K |
|
3338
Prelude Therapeutics
PRLD
$69.6M
| $97K | ﹤0.01% |
+14,616
| New | +$97K |
|
3339
BRF SA
BRFS
$5.86B
| $96K | ﹤0.01% |
41,062
+2,258
| +6% | +$5.28K |
|
3340
QuickLogic
QUIK
$84.4M
| $96K | ﹤0.01% |
14,860
| – | – |
|
3341
Uranium Energy
UEC
$4.96B
| $96K | ﹤0.01% |
27,496
-59,924
| -69% | -$209K |
|
3342
Immunic
IMUX
$75.1M
| $95K | ﹤0.01% |
29,974
-13,685
| -31% | -$43.4K |
|
3343
Lightpath Technologies
LPTH
$243M
| $95K | ﹤0.01% |
88,863
-43,000
| -33% | -$46K |
|
3344
Nine Energy Service
NINE
$28.5M
| $95K | ﹤0.01% |
+36,115
| New | +$95K |
|
3345
CPS Technologies
CPSH
$48.8M
| $94K | ﹤0.01% |
33,583
+7,031
| +26% | +$19.7K |
|
3346
ThredUp
TDUP
$1.43B
| $94K | ﹤0.01% |
+51,246
| New | +$94K |
|
|
LGO
3347
Largo
LGO
$95.6M
| $93K | ﹤0.01% |
17,572
| – | – |
|
3348
Larimar Therapeutics
LRMR
$337M
| $93K | ﹤0.01% |
29,212
+4,474
| +18% | +$14.2K |
|
3349
Praxis Precision Medicines
PRAX
$986M
| $93K | ﹤0.01% |
+2,736
| New | +$93K |
|
3350
GoodRx Holdings
GDRX
$1.39B
| $91K | ﹤0.01% |
19,383
+2,153
| +12% | +$10.1K |
|